Akromegalie
eine Analyse der therapeutischen Optionen und Erfolge
Date
Authors
Collections
Loading...
Abstract
Die Akromegalie - Folge eines Wachstumshormon (STH) sezernierenden Hypophysentumors - ist eine seltene Erkrankung. Bei früher Diagnose ist die Akromegalie gut behandelbar. Unbehandelt - oder zu spät behandelt - führt sie zu hoher Co-Morbidität und verkürzt das Leben. Endokrinologische Therapieziele wurden kürzlich definiert: Heilung bei STH
Acromegaly, caused by a growth hormone (GH)-secreting pituitary adenoma, is a rare disease. If diagnosed early therapeutic results are good. However, untreated or treated belatedly, acromegaly is associated with a high co-morbidity and reduced life-expectancy. The therapeutic goals have recently been defined as follows: complete remission or cure as GH
Acromegaly, caused by a growth hormone (GH)-secreting pituitary adenoma, is a rare disease. If diagnosed early therapeutic results are good. However, untreated or treated belatedly, acromegaly is associated with a high co-morbidity and reduced life-expectancy. The therapeutic goals have recently been defined as follows: complete remission or cure as GH
Description
Keywords
Akromegalie, transspenoidale Hypophysenadenomektomie, Somatostatin-Analoga, Dopamin-Agonist, Acromegaly, transsphenoidale pituitary surgery, somatostatin analogue, dopamin agonist
Dewey Decimal Classification
Citation
Plöckinger, U. (2001). Akromegalie. https://doi.org/10.18452/13753